The similar pro-obesity effect following either daily or twice a week dosing of NT4 (Figs. 4a–f), which in primates has an half-life of less then 30 minutes (data not shown), is incompatible with the hypothesis of TrkB receptor down regulation. The gene discussed is NTF4; the disease is Obesity.